Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Incidence of cytomegalovirus infection in NSCLC cytology (CROSBI ID 693917)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa

Harabajsa, Suzana ; Šefčić, Hajdi ; Vrabec Branica, Božica ; Šimić, Vesna ; Milavić, Marija ; Židovec Lepej, Snježana ; Badovinac, Sonja ; Jakopović, Marko ; Smojver-Ježek, Silvana ; Korać, Petra Incidence of cytomegalovirus infection in NSCLC cytology. 2020

Podaci o odgovornosti

Harabajsa, Suzana ; Šefčić, Hajdi ; Vrabec Branica, Božica ; Šimić, Vesna ; Milavić, Marija ; Židovec Lepej, Snježana ; Badovinac, Sonja ; Jakopović, Marko ; Smojver-Ježek, Silvana ; Korać, Petra

engleski

Incidence of cytomegalovirus infection in NSCLC cytology

Aim: Presence of human cytomegalovirus DNA (HCMV) in lung cancer cells may alter the activity of cellular proto-oncogenes or tumor suppressor genes which further can result in cancer development as well as modulation of response to the cancer treatment. Aim of this study was to determine the incidence of HCMV infection in non-small cell lung cancer (NSCLC) cytology. Methods: This study included 67 NSCLC cytological smears and their DNA isolates from newly diagnosed lung cancer patients hospitalized at the Department of Respiratory Diseases Jordanovac, University Hospital Centre Zagreb. The cytological smears were from samples obtained during bronchoscopy, fine needle aspirations and pleural effusions. The DNA was extracted from NSCLC cytological smears stained by May Grünwald Giemsa staining. The two years retrospective analysis included 34 NSCLC with EGFR gene mutations and 33 NSCLC without EGFR gene mutations. Specific fragments for glycoprotein B (gB) and immediate-early (MIE) gene of HCMV were amplified by polymerase chain reaction method. Results: Among 34 NSCLC with EGFR mutations were 14 males (41, 2%) and 20 females (58, 8%). Among 33 NSCLC without EGFR mutations were 13 males (39, 4%) and 20 females (60, 6%). The median age of both groups was 69 years. Among NSCLC with EGFR mutations were 24 non-smokers, 8 smokers (including ex-smokers), and two with no smoking status. Among NSCLC without EGFR mutations were 23 smokers (including ex-smokers) and 10 non-smokers. The HCMV MIE gene was detected in: 13 (38, 2%) samples of NSCLC with EGFR gene mutations, in one (12, 5%) smoker and 11 (45, 8%) non-smokers, four (28, 6%) males and nine (45, 0%) females. The HCMV MIE gene was not detected in samples without EGFR mutations. The HCMV gB gene was detected in: four (13.3%) samples of NSCLC with EGFR gene mutations and in one (3, 1%) sample without EGFR gene mutations, in three (37, 5%) smokers and one (4, 2%) non-smoker, two (14, 3%) males and two (10, 0%) females. More frequent HCMV infection was determined on the basis of MIE gene detection in NSCLC with EGFR gene mutations (p <0.001). There was no statistically significant association of HCMV (MIE and gB) infection with age, gender, and smoking status in NSCLC with EGFR gene mutations. Conclusion: Our results indicate more frequent HCMV (MIE) infection in NSCLC with EGFR gene mutations. More extensive research is needed to determine the incidence of HCMV infection in NSCLC cytology and its possible role in NSCLC pathogenesis.

cytomegalovirus ; non-small cell lung cancer ; EGFR mutations ; cytology

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

ID2674

2020.

objavljeno

Podaci o matičnoj publikaciji

Podaci o skupu

Toraks 2020 - 10. kongres Hrvatskog torakalnog društva

poster

16.09.2020-19.09.2020

Zagreb, Hrvatska; online; konferencija

Povezanost rada

Kliničke medicinske znanosti, Temeljne medicinske znanosti